Protocol Compliance Guiding Angiotensin II Use in Post Cardiovascular Surgery Vasoplegia.
Ontology highlight
ABSTRACT: Catecholamines and vasopressin are commonly used in patients with post cardiovascular surgery vasoplegia (PCSV). Multimodal therapy, including methylene blue (MB), hydroxocobalamin, and angiotensin II (Ang II), may improve outcomes in patients who remain hypotensive despite catecholamine and vasopressin therapy. However, a standardized approach has not been established. We created a protocol at Emory Healthcare (Emory Protocol), which provides guidance on norepinephrine equivalent dose (NED) and the use of noncatecholamines in the setting of PCSV and sought to determine the clinical significance of adherence to the protocol.Design
Retrospective study.Setting
Multisite study at Emory University Hospital.Patients
Patients receiving Ang II for PCSV in any cardiovascula
SUBMITTER: Ten Lohuis CC
PROVIDER: S-EPMC9243243 | biostudies-literature | 2022 May
REPOSITORIES: biostudies-literature
ACCESS DATA